1,882 product recalls found in this category. Browse through all safety alerts and stay informed.
High Activity Category
This category has a significant number of recalls. Please check regularly for updates.
STAQ Pharma recalled FentaNYL Citrate PF IV injection nationwide after labeling left incorrect or missing lot and expiration dates. Healthcare providers must stop using the product immediately. STAQ Pharma will provide recall instructions by letter.
Pivotal Health Solutions is recalling 34 Quantum Q400 intersegmental heated massage tables sold nationwide in the United States, Canada and Japan. The recall cites heat-function components that can be damaged over time when pressed, risking overheating, smoldering and melting of the vinyl cushion. Clinicians and patients should stop using the device immediately and await manufacturer instructions.
27,868 blister packs of Sucralfate Tablets, 1 g, distributed nationwide by American Health Packaging are recalled. The recall stems from CGMP deviations that prevent the firm from assuring product identity, strength, quality and purity. Health providers and consumers should stop using the product immediately and await guidance.
Glycar SA recalls 18 SJM Pericardial Patch with EnCap Technology 5x10 cm distributed in the US to healthcare facilities. The lot may not meet the required tensile strength specification. Stop use and follow manufacturer instructions provided by Glycar and your healthcare provider. Notification was issued by email.
ibspot recalled Taoscare Motion Sickness Patches, 36-count boxes, sold in Wyoming and Virginia. The recall centers on marketing without an approved NDA or ANDA. Consumers and healthcare providers should stop using the product immediately and contact ibspot for guidance.
STAQ Pharma recalled Ketamine Hydrochloride injections distributed nationwide in the United States. The labeling has incorrect or missing lot and expiration date information. Stop using the product and contact STAQ Pharma or your healthcare provider for guidance.
AstraZeneca recalls 916 Fasenra benralizumab injections distributed nationwide in the United States. The lot is YJ0152 and the NDC is 0310-1730-30. The product is being recalled for lack of sterility assurance. Stop using this product immediately and contact AstraZeneca for guidance.
Rising Pharma Holdings recalled 2,064 bottles of Carbidopa, Levodopa and Entacapone tablets distributed nationwide in the United States. Sealed bottles labeled 25 mg/100 mg/200 mg contained 37.5 mg/150 mg/200 mg instead. Healthcare providers and patients should stop using immediately and await recall letter guidance.
Viona Pharmaceuticals recalled 13,080 Tavaborole Topical Solution 5%, 10 mL bottles distributed nationwide in the United States. The recall covers Tavaborole Topical Solution 5%, Rx only, manufactured by Zydus Lifesciences Ltd. Discoloration linked to RES #97424 prompted the action. Consumers should stop using the product and contact Viona for guidance.
Advanced Pharmaceutical Technology recalled 22,843 cartons of TESTO-100 CIII testosterone pellets on October 3, 2025. The recall follows a risk of microbial contamination that could compromise product sterility. Consumers and healthcare providers should stop using the product immediately and seek guidance.
Almpal recalls its dissolved oxygen test kits sold on Amazon after authorities found the sulfuric acid inside the kit lacked required child-resistant packaging. The recall is active as of Oct 2, 2025. Consumers should stop using the kit and follow disposal and refund instructions from the seller.
ICU Medical recalls 23,203 IV gravity burette sets worldwide. The burette component is missing an internal shutoff valve, which can delay therapy, cause overdelivery, or allow air to be infused. Stop using the device and contact ICU Medical for instructions.
Church & Dwight recalled 21,912 bottles of ZICAM Cold Remedy Medicated Fruit Drops Elderberry from nationwide distribution in the United States. The label did not indicate elderberry as an ingredient though the product contains elderberry. Consumers should stop using the product and contact Church & Dwight for guidance.
Abiomed recalled 10,153 Automated Impella Controllers and related components due to potential cybersecurity vulnerabilities in the operating system. The recall spans multiple international product codes and was first issued for devices distributed nationwide and internationally. Providers should stop using the affected controllers and follow manufacturer instructions immediately.
Camber Pharmaceuticals recalled Ketorolac Tromethamine Injection, USP, 60 mg/2 mL, 2 mL single-dose vials distributed nationwide in the United States. The recall is due to the presence of glass particulates. Healthcare providers and patients should stop using the product immediately and contact Aspiro Pharma Limited at 1-866-495-1995 for guidance.
SHENZHEN ATOMSTACK TECHNOLOGIES recalled material processing laser products on September 30, 2025, due to a missing remote interlock connector. This defect poses a high risk according to federal regulations. Consumers should stop using these devices immediately and follow manufacturer instructions for remedy.
B BRAUN MEDICAL recalled 1,298,454 STREAMLINE BLOODLINE SET FOR DIALOG devices nationwide in the United States after observations of micro-air bubbles and air-in-line alarms linked to damaged arterial and venous connectors. The defect increases the risk of air entering the bloodstream during dialysis. Patients and healthcare providers should stop using this device immediately and follow the recall
Acuity Specialty Products recalled hand sanitizer products sold nationwide due to potential methanol presence. The recall covers Wyandotte, Sanifect E3 ethanol-based sanitizer products manufactured by AFCO. The issue stems from unperformed receipt testing on incoming alcohol components. Consumers and healthcare providers should stop use immediately.
Acella Pharmaceuticals recalls doxycycline hyclate tablets, 100 mg, 500-count bottles distributed nationwide in the USA. Stability testing found the lot did not meet dissolution specifications. Consumers and healthcare providers should stop using the product immediately and contact Acella for guidance.
Medline Industries recalled 222,800 alcohol prep pads nationwide on Sept. 29, 2025 due to subpotent potency. The pads are 2-ply, 70% isopropyl alcohol. Stop using immediately and contact Medline or your healthcare provider for guidance.